Coagulation factor VIIa binds to herpes simplex virus 1‐encoded glycoprotein C forming a factor X‐enhanced tenase complex oriented on mem

March 7, 2020

Lin B.H., Sutherland M.R., Rosell F.I., et al.

Journal of Thrombosis and Haemostasis 2020, doi: 10.1111/jth.14790

Abstract

The cell membrane‐derived initiators of coagulation, tissue factor (TF) and anionic phospholipid (aPL), are constitutive on the herpes simplex virus type 1 (HSV1) surface, bypassing physiological regulation. TF and aPL accelerate proteolytic activation of factor (F) X to FXa by FVIIa to induce clot formation and cell signaling. Thus, infection in vivo is enhanced by virus surface TF. HSV1‐encoded glycoprotein C (gC) is implicated in this tenase activity by providing viral FX binding sites and increasing FVIIa function in solution.

View Publication
 

Topics: Virology, Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

 

Previous Article
Characterization and structure of the vaccinia virus NF-κB antagonist A46
Characterization and structure of the vaccinia virus NF-κB antagonist A46

Up next
Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain.
Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain.

Ready to characterize your most challenging interactions?

Discover tools to measure binding affinity

Learn more